LATEST PSYCHEDELICS STOCKS NEWS

923 views4 min read

Lobe Sciences Announces Closing of Private Placement

Lobe Sciences
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe"), a Canadian Biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease, today announced that it has closed a non-brokered private placement of unit... Read More...
392 views8 min read

Delic Corp to Present on Strategy and Expansion of Nation’s Largest Ketamine Clinic Network at H.C. Wainwright Annual Global Investment Conference

Delic Holdings
Matt Stang, executive chairman of Delic, will discuss the company's efforts to grow the clinic footprint, accept a wider selection of insurance options, and its strategic outlook for the remainder of the yearVANCOUVER, BC, Sept. 8, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) ( OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and t... Read More...
Calendar699 views4 min read

Field Trip Health & Wellness to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Field Trip Health
TORONTO, Sept. 08, 2022 -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), a global leader in psychedelic therapies, today announced it will participate in a virtual fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference taking place September 12-14, 2022. A recording of the fires... Read More...
841 views10 min read

Optimi Health Signs First International Mushroom Supply Agreement with UK-based Avida Global

Optimi Health
Optimi Health Corp.EU-GMP, operational, and service excellence to drive world-class sales pipelineFunctional MushroomsFunctional mushrooms grown at Optimi Health facility in Princeton, British Columbia.Lion's ManeLion's Mane mushrooms grown at Optimi Health facility in Princeton, British Columbia.Optimi LifeOptimi Life BundleVANCOUVER, Br... Read More...
565 views3 min read

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors

Bright Minds Biosciences
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, British Columbia, Sept. 07, 2022 -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology com... Read More...
1166 views8 min read

Delic Announces Postponement of Meet Delic Conference

Delic Holdings
Meet Delic will now be held on October 14 and 15, 2023 in Las Vegas Tickets purchased for Meet Delic 2022 will be honored at next year's event VANCOUVER, BC, Sept. 6, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) ( OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today announced the postponement of... Read More...
Calendar1189 views9 min read

Red Light Holland Announces Live Investor Q&A Session at 2:00 PM (EST) on Thursday, September 8, 2022

Red Light Holland
Toronto, Ontario--(Newsfile Corp. - September 2, 2022) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America, and a premium brand of psilocybin t... Read More...
Financials1401 views7 min read

Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins

Avenir Wellness Solutions
Balance Sheet and Governance Strengthened with Asset Sale and Board Appointments New Marketing Programs Showing Encouraging Early Results OXNARD, Calif., Sept. 02, 2022 -- CURE Pharmaceutical Holding Corp. (OTC: CURR) (“CURE”), a proprietary broad platform and wellness technology company, today announced results for the quarter ended June... Read More...
862 views6 min read

Lobe Sciences and Cantheon Capital Enter into Exclusive Investment Agreement to Fund $1.5M USD Toward Clinical Trials in Australia

Lobe Sciences
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe"), a Canadian Biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease today announced it has entered into a term sheet contemplating convertible n... Read More...
703 views3 min read

Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022

Numinus Wellness
VANCOUVER, BC, Aug. 31, 2022 - Numinus Wellness Inc. ("Numinus") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in the H.C. Wainwright 24th Annual Global Investment Conference to be held at the Lotte ... Read More...
1189 views4 min read

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndrome

Bright Minds Biosciences
VANCOUVER, British Columbia, Aug. 31, 2022 -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on developing novel drugs for the targeted treatment of neuropsychiatric disorders, epilepsy, and pain, today announced that it has dosed the first patient in a Phase I... Read More...
Financials1231 views10 min read

Field Trip Health & Wellness Ltd. Reports Fiscal First Quarter 2023 Financial and Operating Results

Field Trip Health
Completed corporate reorganization on August 11, 2022 separating the drug development (“Reunion Neuroscience Inc.” or “Reunion”) and healthcare and wellness (“Field Trip Health & Wellness” or “Field Trip”) divisions into two separate public companies (the “Spinout Transaction”).Field Trip received listing approval from the TSX Venture... Read More...
54 views9 min read

Optimi Health Announces Canadian Retail and E-Commerce Distribution Agreements for Functional Mushroom Supplements and Appoints Chief Financial Officer to its Board of Directors

Optimi Health
Optimi Health Corp.Deals position Optimi Life nutraceutical brand for international distributionOptimi LifeOptimi Life BundleOptimi LifeOptimi LifeOptimi LifeOptimi LifeVANCOUVER, British Columbia, Aug. 25, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by H... Read More...
CalendarFinancials115 views4 min read

Field Trip Health & Wellness Ltd. Schedules Fiscal First Quarter 2023 Conference Call for Tuesday, August 30, 2022, at 8:30 A.M. ET

Field Trip Health
TORONTO, Aug. 23, 2022 -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (the "Company" or “Field Trip”), a global leader in psychedelic therapies, announced today that it plans to release financial results for its fiscal 2023 first quarter for the three-month period ended June 30, 2022, after market close on Monday, August 29, 2022. ... Read More...
1271 views4 min read

Lobe Sciences Announces Update on Corporate Slide Deck Highlighting its Psilocin Compounds and Development Plans

Lobe Sciences
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe"), a Canadian Biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease today announced it has updated its Corporate Slide Deck which among other init... Read More...
Capital Raise1384 views5 min read

Mydecine Innovations Group Announces Private Placement; Interim Changes to Management and Board of Directors

Mydecine Innovations Group
DENVER, Aug. 19, 2022 -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD, is pleased to announce that it has... Read More...
1225 views3 min read

Pure Extracts Delivers Its Largest Shipments to Launch its Newest Vape Product

Pure Extracts Technologies
VANCOUVER, British Columbia, Aug. 17, 2022 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pu... Read More...
49 views3 min read

Field Trip Health & Wellness Ltd. to Commence Trading on the TSX Venture Exchange on August 17, 2022

Field Trip Health
TORONTO, Aug. 16, 2022 -- Field Trip Health & Wellness Ltd. (the "Company" of “Field Trip”), a global leader in the development and delivery of psychedelic therapies, is pleased to announce that its common shares (the "Shares") will commence trading on the TSX Venture Exchange (“TSXV”) under the ticker symbol “FTHW” at the opening of ... Read More...
60 views7 min read

Delic Announces Two Key Executive Appointments

Delic Holdings
Matt Stang, Co-founder and CEO of Delic, and Kevin Nicholson, COO of Delic, have been elevated to Executive Chairman and Chief Executive Officer, respectively. VANCOUVER, BC, Aug. 16, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today shared detail... Read More...
Financials49 views50 min read

Mydecine Reports Financial Results for the Second Quarter of Fiscal Year 2022

Mydecine Innovations Group
DENVER, Aug. 15, 2022 -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine"), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today reported financial results for the six months ended June 30, 2022. Financial Results for the Six Months Ended June 30, 2022 Net Los... Read More...
123 views4 min read

Lobe Sciences Enters into an Exclusive Agreement With iNGENu to Conduct Clinical Trials in Australia

Lobe Sciences
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe"), a Canadian Biopharmaceutical company committed to discovering and developing psychedelic derived medicines for neurologic and brain disease today announced it has entered into an exclusive agreement with iNGENū Pty Ltd... Read More...
128 views11 min read

Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients

Optimi Health
Optimi Health Corp.Blue Serenity (English)Optimi Health's, Blue Serenity psilocybin.Blue Serenity (English)Optimi Health's, Blue Serenity psilocybin.Blue Serenity Psilocybin PackagingOptimi Health's Blue Serenity psilocybin.Blue Serenity brings science and compassion together, will cement Thomas Hartle’s legacy as a Canadian psychedelic i... Read More...
136 views7 min read

Optimi Health To Launch Therapeutic Psilocybin Product In Partnership With Patient Advocate Thomas Hartle

Optimi Health
VANCOUVER, British Columbia, Aug. 08, 2022 -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a homegrown, Canadian company licensed by Health Canada to produce natural, scalable, and accessible psychedelic and functional mushrooms, as well as synthetic formulations for transformational human experie... Read More...
Financials696 views32 min read

COMPASS Pathways plc announces second quarter 2022 financial results and business highlights

COMPASS Pathways plc
COMPASS PathwaysLONDON, Aug. 04, 2022 --Highlights:Kabir Nath appointed as Chief Executive Officer Phase III program submitted to FDA and under reviewCOMP360 phase II study in anorexia nervosa launchedCash position at 30 June 2022 of $207.2 millionConference call today at 8:00am ET (1:00pm UK)COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”... Read More...
Calendar569 views8 min read

Field Trip Health Ltd. Receives Conditional Approval for Listing of Common Shares of Field Trip Health & Wellness Ltd. on the TSX Venture Exchange

Field Trip Health
– Field Trip Health & Wellness Ltd. to list on the TSX Venture Exchange, with first day of trading expected to occur on or about August 17, 2022. – Field Trip Discovery to be renamed Reunion Neuroscience Inc., remaining listed on the NASDAQ Stock Market and Toronto Stock Exchange. TORONTO, Aug. 04, 2022 -- Field Trip Health Ltd. (TSX:... Read More...
41 views4 min read

Delic Completes Offering Of Debentures

Delic Holdings
VANCOUVER, BC, July 29, 2022 - Delic Holdings Corp ("Delic") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, is pleased to announce that it completed the sale of 1,240 units (the "Units") at a price of $1,000 per Unit for aggregate gross proceeds of $1,240,000, on July 27, 2022 (the "Clo... Read More...
118 views3 min read

Silo Pharma Announces Positive Results from its Topically Administered Formulation of Ketamine

Silo Pharma
Silo shows reversal of allodynia and hyperalgesia using its selected formulation and partnered, patented delivery system ENGLEWOOD CLIFFS, N.J, July 27, 2022 -- Silo Pharma, Inc . (OTCQB: SILO), a development-stage biopharmaceutical company today announced that its topically administered Ketamine reached a positive end point in an animal ... Read More...
CalendarFinancials114 views3 min read

COMPASS Pathways plc to announce second quarter 2022 financial results on 4 August 2022

COMPASS Pathways plc
COMPASS PathwaysLONDON, July 26, 2022 -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter 2022, and provide an update on recent business developments on 4 Au... Read More...
101 views8 min read

Delic 2021 Revenue Shows Strong Growth as Nation’s Largest Ketamine Clinic Chain, Continues Expansion of Mental Health Wellness Services

Delic Holdings
Ketamine Wellness Centers (KWC) Approaches 100,000 Treatments, Expands FDA-Approved SPRAVATO® to Minneapolis, Salt Lake City, Dallas with More Locations Soon KWC, Serving the Most Patients in the U.S., Adds NAD+ Therapy and Launches Ketamine Wellness Integrated Therapist Directory VANCOUVER, BC, July 21, 2022 - Delic Holdings Corp ("DELI... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!